American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Top Stories

Don’t Miss these ACS Cancer Programs Sessions at Clinical Congress 2020

Clinical Congress 2020Registration is now open for the virtual ACS Clinical Congress 2020.

Although there is no registration fee, all attendees must register online to gain access to Clinical Congress sessions. Your registration will include access to the virtual Clinical Congress, including named lectures, panel sessions, the Academy’s Symposium and special lunchtime sessions, Scientific Forum presentations, Video-based Education Sessions, Meet-the-Expert Sessions, the Resident Program, and the Medical Student Program. Registration also will include on-demand access to this content through at least the end of the year.

Register today to take advantage of ACS Cancer Programs’ wide range of educational sessions (all times listed are Central Time zone):

Monday, October 5

Panel Session: Bringing Cancer Genetic Testing Into the Mainstream
9:00–10:00 am

Panel Session: Multidisciplinary Management of Melanoma
1:00–2:00 pm

Tuesday, October 6

Panel Session: New Frontiers in Targeted Therapy in Breast Cancer: What is the Surgeon’s Role?
2:00–3:00 pm

Wednesday, October 7

Panel Session: Treatment Strategies and Evolving Therapies for Retroperitoneal Sarcomas (RPS)
9:00–10:00 am

Panel Session: Ten Hot Topics in Surgical Oncology
10:00–11:00 am

Panel Session: Multidisciplinary Management of Locally Advanced Colorectal Cancer
10:00–11:00 am

Panel Session: Best Practice in Treatment of Gastric Cancer
11:00 am–12:00 noon

CoC Oncology Lecture: Cancer Care: Medicine, Meet Math
Professor Sir Murray F. Brennan, GNZM, MD, ChM, FACS, FRACS, Senior Vice President of International Programs and the Benno C. Schmidt Chair of Clinical Oncology at Memorial Sloan Kettering Cancer Center, New York, NY
1:00–2:00 pm

Panel Session: My Patient Has Breast Cancer: What Comes Next?
2:00–3:00 pm

Mark Your Calendars for the Next Cancer Informatics Journal Club Discussion

Are you curious about the role of informatics in cancer care, or wondering what role providers can have in shaping the future of clinical informatics? If so, consider joining the Cancer Informatics Journal Club.

Information and knowledge are tools of the trade for all health care providers, and vital to the practice of medicine. Clinicians with academic interests have long enjoyed opportunities to contribute to the collective knowledge of medicine through writing and editing books and generating and distributing new observations and findings in journal articles.

As we move away from traditional print technologies and shift towards digital information technologies, the opportunities for the creation of practice-supporting, point-of-care tools like risk calculators and clinical decision aids seem right around the corner; yet delivering on the promise of modern information technologies will require the engagement of clinicians. It will be necessary for at least some clinicians to learn new forms of information technologies, knowledge management, and communication strategies.

To introduce cancer providers to the field of clinical informatics and how it is shaping the current and future landscape of cancer care, we are starting a Cancer Informatics Journal Club. Everyone is welcome to join. Following the inaugural meeting on September 14, the club will meet on the third Monday of each month for the remainder of 2020: October 19, November 16, and December 21. Articles will be sent in advance of each call with questions to stimulate discussion; and we anticipate hosting debates, panels panels, and guest speakers as the club grows.

For more information, contact jfrancescatti@facs.org.

Accreditation Fee Information for 2021 Updated

The ACS Cancer Programs annual accreditation fee information resource has been updated for 2021 and is available in the following locations:

  • For CoC programs, it is located on the home page of CoC Datalinks under Resources
  • For NAPRC and NAPBC programs, it is located in the Resources section of the ACS Quality Portal

Help ACS Cancer Programs Stay Connected With You and Your Team

Please remember to review and update your staff contacts in the ACS Cancer Programs portals on a regular basis. We want to make sure that you and your staff are receiving the latest information regarding all Cancer Programs activities and programs, such as new National Cancer Database (NCDB) tools, standards, site visit updates, educational opportunities, and information regarding your accreditation.

Please take a few minutes now to review and update contact information for current cancer program staff and leadership.

  • For CoC programs, log into CoC Datalinks and click on the Manage Staff Contacts link in the Main Facility Activity menu 
  • For NAPBC and NAPRC programs, please log into the ACS Quality Portal and click on Site Contacts

It is critical that your program has identified a primary and a billing contact. This can be the same staff member. If a billing contact is not selected, your program may not receive annual invoices, which may lead to a disruption in access or loss of accreditation.

Ensure that all names, titles and e-mail addresses are complete and accurate. Remember to remove staff members who are no longer with your program.

If you have questions, please contact the CoC, NAPBC, or NAPRC.

NCDB to Freeze Applications and Data Submissions in Preparation for RCRS Launch

In response to the valued feedback from our accredited cancer programs, the Commission on Cancer's (CoC) National Cancer Database (NCDB) is launching a significant improvement to our technological infrastructure. We are pleased to announce that the Rapid Cancer Reporting System (RCRS) will be going live Monday, September 28, 2020.

In preparation for the go-live date, the NCDB will freeze all applications and data submissions–including the Rapid Quality Reporting System (RQRS)–to allow us to prepare for the data migration from our existing systems to the new platform. All the reporting tools, including data submissions, will be unavailable September 14–28, 2020. Once RCRS is live, programs can submit files using the upload function in the RCRS platform.

The RQRS (v1.1) hyperlink in CoC Datalinks will remain open until January 1, 2021 to allow programs to copy and paste any case-level notes from RQRS into RCRS notes. However, submission of case updates will only occur in the RCRS uploader. RCRS will accept data in the current North American Association of Central Cancer Registries (NAACCR) v18 format, and file uploads can include new, updated, and completed cases (formerly for RQRS or Call for Data files).

To orient all users to the new RCRS platform:

  • Information to enroll for the Wednesday October 28, 2020 RCRS orientation webinar will be forthcoming.
  • Function and report-specific training videos will be posted to the RCRS page of the Cancer Programs website following go-live.
  • The ACS Cancer Programs newsletter, Cancer Programs News, published every other Thursday, will have the latest updates on RCRS.
  • All communications will be archived and available on the RCRS page of the Cancer Programs website.

For questions, contact NCDB@facs.org.

NCDB Previews Upcoming Changes to STORE Manual

NCDBA new version of STOREv2021 will be released for diagnosis years beginning with January 1, 2021. To prepare registrars for upcoming changes, we will be communicating highlighted changes in Cancer Programs News.

Regional Lymph Nodes Examined [830]

In STORE 2018 (page 168), the second-to-the-last bullet point was updated to include topography sites that LNs examined should be coded to 99. Also included are updated exclusions for Hodgkin and Non-Hodgkin lymphoma, Myeloma/Plasma Cell Disorders and Other Ill-Defined Primary Sites.:

Primary sites always coded 99. For the following primary sites and histologies, the Regional Nodes Examined field is always coded as 99: C420, C421, C423-C424, C700-C709, C710-C729, C751-C753, C761-C768, C770-C779, or C809.

For the following schemas, the Regional Nodes Examined field is always coded as 99.

  • Placenta
  • Brain and Cerebral Meninges
  • Other Parts of Central Nervous System
  • Intracranial Gland
  • Hematopoietic, Reticuloendothelial, Immunoproliferative and Myeloproliferative Neoplasms
  • Hodgkin and non-Hodgkin Lymphoma
  • Excludes cases collected in the following schemas: Lymphoma Ocular Adnexa, Primary Cutaneous Lymphomas and Mycosis Fungoides—Myeloma and Plasma Cell Disorders
  • Excludes histology 9734—Other and Ill-Defined Primary Sites
  • Excludes Spleen (C422)—Unknown Primary Site

Regional Lymph Nodes Positive [820]

In STORE 2018 (page 171), the second-to-the-last bullet point was updated to include topography sites LNs examined that should be coded to 99. Also included are updated exclusions for Hodgkin and Non-Hodgkin Lymphoma, Myeloma/Plasma Cell Disorders and Other Ill-Defined Primary Sites.

Primary sites always coded 99. For the following primary sites and histologies, the Regional Nodes Positive field is always coded as 99: C420, C421, C423-C424, C700-C709, C710-C729, C751-C753, C761-C768, C770-C779, or C809. For the following schemas, the Regional Nodes Positive field is always coded as 99.

  • Placenta
  • Brain and Cerebral Meninges
  • Other Parts of Central Nervous System
  • Intracranial Gland
  • Hodgkin and non-Hodgkin Lymphoma
  • Excludes cases collected in the following schemas: Lymphoma Ocular Adnexa, Primary Cutaneous Lymphomas and Mycosis Fungoides—Hematopoietic, Reticuloendothelial, Immunoproliferative and Myeloproliferative Neoplasms; Myeloma and Plasma Cell Disorders
  • Excludes histology 9734—Other and Ill-Defined Primary Sites
  • Excludes Spleen (C422)—Unknown Primary Site

CoC Announces Requirements for 2021

Commission on CancerThe Commission on Cancer (CoC) recently sent a communication to all accredited programs outlining specific standards required for implementation in 2021 as outlined in Optimal Resources for Cancer Care (2020 Standards). Programs scheduled for a site visit in 2022 will be reviewed on 2020 and 2021 program activity.

Additional information can be found on the CoC website.

CoC Templates Updated for 2020 Standards

Four Pre-Review Questionnaire (PRQ) templates, which can be found on the Commission on Cancer (CoC) Datalinks Activity Menu, have been modified since their original release in June 2020:

  • Oncology Nursing template (Standard 4.2)
  • Cancer Committee template (Standards 2.1, 2.3, and 2.4)
  • Multidisciplinary Cancer Case Conference template (Standard 2.5)
  • Physician Certification Credentials template (Standard 4.1)

For details on the revisions made to each template, please review the PRQ Template Change Log on the CoC Datalinks Activity Menu.

Download Free Breast Cancer Awareness Month Poster

2020 Breast Cancer Awareness PosterOctober is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your accreditation status.

To help you promote this event within your program and community, the NAPBC and CoC created a free poster that you can download, print, and display. To take advantage of this resource:

  • Programs accredited by NAPBC may log in to the NAPBC Portal and click on Marketing Resources
  • Programs accredited by the CoC may log in to CoC Datalinks and click on Marketing Resources

Please let us know how you observe this event by sending your articles, activities, and photographs to srubin@facs.org


ACS CRP Provides Update on A231601CD OPTI-Surg Study

Thirty NCI Community Oncology Research Program (NCORP) sites are accruing patients to the presurgical optimization intervention study known as OPTI-Surg. This Cancer Care Delivery Research (CCDR) study examines the efficacy of a rapid frailty assessment screening and referral tool in busy clinical practices. This research aims to improve presurgical cancer care for patients aged 70 and above. Alliance/ACS CRP CCDR Committee leadership applauds participating sites for their commitment to patient care while navigating new COVID-19 safety protocols. The study team looks forward to a fruitful discussion with participating sites during the OPTI-Surg Breakout Session scheduled during the Fall Alliance for Clinical Trials in Oncology meeting this November 5-7, 2020.

ACS Cancer Programs Thank Quality and Safety Conference Moderators and Speakers

2020 ACS Quality and Safety ConferenceThe American College of Surgeons (ACS) Cancer Programs thank all the moderators and speakers who shared their knowledge and expertise at last month’s 2020 ACS Quality and Safety Conference VIRTUAL. If you missed these sessions live, you may still view the on-demand sessions at no charge on the ACS Quality and Safety Conference website.

The Cancer Patient Journey: Lessons Learned From COVID-19
Moderator: Scott Kurtzman, MD, FACS, Waterbury, CT
Speakers: Lawrence Shulman, MD, FCAP, FASCO, Philadelphia, PA
Katharine Yao, MD, FACS, Evanston, IL
Sally Werner, RN, BSN, MSHA, Washington, DC

Quality Improvement Basics: Using Data to Drive Quality
Moderator: Daniel Boffa, MD, FACS, New Haven, CT
Speakers: Elizabeth Habermann, PhD, MPH, Rochester, MN
Sharon Lum, MD, FACS, Loma Linda, CA
David Foley, MD, FACS, Louisville, KY

Building a Quality Improvement Program: The Fundamentals and Practical Solutions From the Field
Moderator: Laurie Kirstein, MD, FACS, Westfield, NJ
Speakers: Jennifer Rosen, MD, FACS, Washington, DC
Rebecca Snyder, MD, FACS, Greenville, NC
Timothy Pearman, PhD, Chicago, IL

Breast Cancer Operative Standards and Synoptic Operative Reports: Bringing the Evidence to Your Workflow
Moderator: Kelly Hunt, MD, FACS, Houston, TX
Speakers: Sarah Blair, MD, FACS, La Jolla, CA
Judy Boughey, MBBCh, FACS, Rochester, MN
Diana Dickson-Witmer, MD, FACS, Newark, DE

Colon and Rectal Cancer Synoptic Operative Reports: Bringing the Evidence to Your Workflow
Moderator: Matthew Katz, MD, FACS, Houston, TX  
Speakers: George Chang, MD, FACS, Houston, TX
Arden Morris, MD, FACS, Stanford, CA
Steven Wexner, MD, FACS, Weston, FL

Aligning ACS Cancer Program Quality Initiatives With Your Hospital Quality Priorities
Moderator: Katharine Yao, MD, FACS, Evanston, IL
Speakers: Richard Bleicher, MD, FACS, Philadelphia, PA
David Dietz, MD, FACS, Bentleyville, OH
Thomas Hensing, MD, Evanston, IL

Delivering Real Time Cancer Biology: The Roles of Humans and Machines
Moderator: Heidi Nelson, MD, FACS, Medical Director, ACS Cancer Programs, Rochester, MN
Speakers: Nicholas Chia, PhD, Rochester, MN
Carolyn Compton, MD, PhD, FCA, Scottsdale, AZ
Richard Moldwin, MD, PhD, Northfield, IL

Registration is required to view these and other Quality and Safety Conference sessions. The ACS Cancer Programs sessions can be accessed by clicking the Cancer link under Topics of Interest. These on-demand sessions will be available for viewing through the end of the year.